摘要
对斑蝥素的结构进行改造,可增强其抗癌活性,降低毒性〔1~3〕.作者参照文献〔4〕合成了两个新的5,6二溴去甲基斑蝥亚胺衍生物(Ⅲa,Ⅲb)(见图1),做了抗癌活性筛选,并用125I对化合物(Ⅲa)进行了标记,观测了其在动物体内的分布.Fig1Sy...
The two new 5,6 dibromo norcantharidinimide derivatives (Ⅲa) and (Ⅲb) were prepared.A simple,rapid method was described for the labelling of 5,6 dibromo norcantharidinimide derivatives with 125 I. In this paper,the radiolabelling ratio was 96 9% in \%T\%=80 ℃,pH=6,\%t\%=30 min.Two new 5,6 dibromo norcantharidinimide derivatives (Ⅲa) and (Ⅲb) were tested for the inhibition of the Carcinoma cells.It was shown that the 5,6 dibromo norcantharidinimide derivatives(Ⅲa)to Carcinoma cells(KB,HCT,Bel) had the best antitumor activity,it′s inhibition ratio to KB,HCT,Bel were 45 7%,0,41 7%.The in vivo distribution of 125 I 5,6 dibromo norcantharidinimide derivatives(Ⅲa)in the mouse was studied.It was shown that the high uptake of 125 I 5,6 dibromo norcantharidinimide derivatives(Ⅲa)was found in the liver,lungs and the kidney.
出处
《中国药物化学杂志》
CAS
CSCD
1999年第1期46-47,共2页
Chinese Journal of Medicinal Chemistry
关键词
斑蝥亚胺
衍生物
^125I
标记
抗肿瘤
体内分布
5
6 dibromo norcantharidinimide derivatives
iodine 125 labelling
antitumor activity
animal distribution